The CRP velocity refers to the variation of this biomarker’s serum levels after seriated measurements; recent results already demonstrate the correlation between increasing hs-CRP and a poorer LVEF following an acute myocardial infarction [161], the same pattern observed in the case of COVID-19’s outcome, as reported in an extensive meta-analysis [162]. This evidence concerns the gene CRP and acute myocardial infarction.